Search Results - "Lansdorp – Vogelaar, Iris"

Risk‐stratified strategies in population screening for colorectal cancer by Lansdorp‐Vogelaar, Iris, Meester, Reinier, Jonge, Lucie, Buron, Andrea, Haug, Ulrike, Senore, Carlo

“…Colorectal cancer (CRC) screening has been demonstrated to reduce CRC incidence and mortality. However, besides such benefits, CRC screening is also associated…”
Get full text

Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths by Zauber, Ann G, Winawer, Sidney J, O'Brien, Michael J, Lansdorp-Vogelaar, Iris, van Ballegooijen, Marjolein, Hankey, Benjamin F, Shi, Weiji, Bond, John H, Schapiro, Melvin, Panish, Joel F, Stewart, Edward T, Waye, Jerome D

“…On the basis of long-term follow-up data from the National Polyp Study, the authors estimate that mortality from colorectal cancer was about 50% lower among…”
Get full text

The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline by Peterse, Elisabeth F. P., Meester, Reinier G. S., Siegel, Rebecca L., Chen, Jennifer C., Dwyer, Andrea, Ahnen, Dennis J., Smith, Robert A., Zauber, Ann G., Lansdorp‐Vogelaar, Iris

“…BACKGROUND In 2016, the Microsimulation Screening Analysis‐Colon (MISCAN‐Colon) model was used to inform the US Preventive Services Task Force colorectal…”
Get full text

Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018 by Meester, Reinier G. S., Doubeni, Chyke A., Zauber, Ann G., Goede, S. Luuk, Levin, Theodore R., Corley, Douglas A., Jemal, Ahmedin, Lansdorp‐Vogelaar, Iris

“…BACKGROUND The National Colorectal Cancer Roundtable, a national coalition of public, private, and voluntary organizations, has recently announced an…”
Get full text

Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates by Edwards, Brenda K., Ward, Elizabeth, Kohler, Betsy A., Eheman, Christie, Zauber, Ann G., Anderson, Robert N., Jemal, Ahmedin, Schymura, Maria J., Lansdorp‐Vogelaar, Iris, Seeff, Laura C., van Ballegooijen, Marjolein, Goede, S. Luuk, Ries, Lynn A. G.

“…BACKGROUND. The American Cancer Society, the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American…”
Get full text

Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline by Meester, Reinier G. S., Peterse, Elisabeth F. P., Knudsen, Amy B., de Weerdt, Anne C., Chen, Jennifer C., Lietz, Anna P., Dwyer, Andrea, Ahnen, Dennis J., Siegel, Rebecca L., Smith, Robert A., Zauber, Ann G., Lansdorp‐Vogelaar, Iris

“…BACKGROUND Colorectal cancer (CRC) risk varies by race and sex. This study, 1 of 2 microsimulation analyses to inform the 2018 American Cancer Society CRC…”
Get full text

Comparative benefit and cost‐effectiveness of mailed‐out faecal immunochemical tests vs collection at the general practitioner by Peterse, Elisabeth F. P., Osoro, Caroline B., Bardou, Marc, Lansdorp‐Vogelaar, Iris

“…Summary Background Participation in the colorectal cancer screening programme in France has been well below the 45% considered acceptable by European…”
Get full text

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention by Lansdorp-Vogelaar, Iris, PhD, Sharp, Linda, PhD

“…Abstract Gastric cancer is the second leading cause of cancer-related death worldwide. A meta-analysis of seven randomized controlled trials concluded that…”
Get full text

Measures of longitudinal adherence to fecal‐based colorectal cancer screening: Literature review and recommended approaches by Doria‐Rose, V. Paul, Lansdorp‐Vogelaar, Iris, McCarthy, Sharon, Puricelli‐Perin, Douglas M., Butera, Vicent, Segnan, Nereo, Taplin, Stephen H., Senore, Carlo

“…The success of fecal occult blood‐based colorectal cancer screening programs is dependent on repeating screening at short intervals (ie, every 1‐2 years). We…”
Get full text

The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies by Koopmann, Brechtje D. M., Omidvari, Amir‐Houshang, Lansdorp‐Vogelaar, Iris, Cahen, Djuna L., Bruno, Marco J., Kok, Inge M. C. M.

“…Evidence supporting the effectiveness of pancreatic cancer (PC) screening is scant. Most clinical studies concern small populations with short follow‐up…”
Get full text

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening by Kooyker, Arthur I., Toes‐Zoutendijk, Esther, Opstal‐van Winden, Annemieke W.J., Spaander, Manon C.W., Buskermolen, Maaike, Vuuren, Hanneke J., Kuipers, Ernst J., Kemenade, Folkert J., Ramakers, Chris, Thomeer, Maarten G.J., Dekker, Evelien, Nagtegaal, Iris D., Koning, Harry J., Leerdam, Monique E., Lansdorp‐Vogelaar, Iris

“…The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We…”
Get full text

Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis by Steinberg, Julia, Hughes, Suzanne, Hui, Harriet, Allsop, Matthew J, Egger, Sam, David, Michael, Caruana, Michael, Coxeter, Peter, Carle, Chelsea, Onyeka, Tonia, Rewais, Isabel, Monroy Iglesias, Maria J, Vives, Nuria, Wei, Feixue, Abila, Derrick Bary, Carreras, Giulia, Santero, Marilina, O'Dowd, Emma L, Lui, Gigi, Tolani, Musliu Adetola, Mullooly, Maeve, Lee, Shing Fung, Landy, Rebecca, Hanley, Sharon J B, Binefa, Gemma, McShane, Charlene M, Gizaw, Muluken, Selvamuthu, Poongulali, Boukheris, Houda, Nakaganda, Annet, Ergin, Isil, Moraes, Fabio Ynoe, Timilshina, Nahari, Kumar, Ashutosh, Vale, Diama B, Molina-Barceló, Ana, Force, Lisa M, Campbell, Denise Joan, Wang, Yuqing, Wan, Fang, Baker, Anna-Lisa, Singh, Ramnik, Salam, Rehana Abdus, Yuill, Susan, Shah, Richa, Lansdorp-Vogelaar, Iris, Yusuf, Aasim, Aggarwal, Ajay, Murillo, Raul, Torode, Julie S, Kliewer, Erich V, Bray, Freddie, Chan, Kelvin K W, Peacock, Stuart, Hanna, Timothy P, Ginsburg, Ophira, Van Hemelrijck, Mieke, Sullivan, Richard, Roitberg, Felipe, Ilbawi, André M, Soerjomataram, Isabelle, Canfell, Karen

“…While previous reviews found a positive association between pre-existing cancer diagnosis and COVID-19-related death, most early studies did not distinguish…”
Get full text

Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT‐based CRC screening program by Breekveldt, Emilie C. H., Toes‐Zoutendijk, Esther, Schootbrugge‐Vandermeer, Hilliene J., Jonge, Lucie, Kooyker, Arthur I., Spaander, Manon C. W., Vuuren, Anneke J., Kemenade, Folkert J., Ramakers, Christian, Dekker, Evelien, Nagtegaal, Iris D., Leerdam, Monique E., Lansdorp‐Vogelaar, Iris

“…The interval colorectal cancer (CRC) rate after negative fecal immunochemical testing (FIT) is an important quality indicator of CRC screening programs. We…”
Get full text

Risk factors for advanced colorectal neoplasia and colorectal cancer detected at surveillance: a nationwide study in the modern era by Smits, Lisanne J H, Siebers, Albert G, Lissenberg‐Witte, Birgit I, Lansdorp‐Vogelaar, Iris, Kouwen, Mariette C A, Tuynman, Jurriaan B, Grieken, Nicole C T, Nagtegaal, Iris D

“…Aim Recommendations for surveillance after colonoscopy are based on risk factors for metachronous advanced colorectal neoplasia (AN) and colorectal cancer…”
Get full text

Colorectal cancer deaths attributable to nonuse of screening in the United States by Meester, Reinier G.S., MSc, Doubeni, Chyke A., MD, MPH, Lansdorp-Vogelaar, Iris, PhD, Goede, S. Lucas, MSc, Levin, Theodore R., MD, Quinn, Virginia P., PhD, Ballegooijen, Marjolein van, MD, Corley, Douglas A., MD, PhD, Zauber, Ann G., PhD

“…Abstract Purpose Screening is a major contributor to colorectal cancer (CRC) mortality reductions in the United States but is underused. We estimated the…”
Get full text

Identifying key factors for the effectiveness of pancreatic cancer screening: A model‐based analysis by Koopmann, Brechtje D. M., Harinck, Femme, Kroep, Sonja, Konings, Ingrid C. A. W., Naber, Steffie K., Lansdorp‐Vogelaar, Iris, Fockens, Paul, Hooft, Jeanin E., Cahen, Djuna L., Ballegooijen, Marjolein, Bruno, Marco J., Kok, Inge M. C. M.

“…Pancreatic cancer (PC) survival is poor, as detection usually occurs late, when treatment options are limited. Screening of high‐risk individuals may enable…”
Get full text

Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum‐based chemotherapy by Breekveldt, Emilie C. H., Ykema, Berbel L. M., Bisseling, Tanya M., Moons, Leon M. G., Spaander, Manon C. W., Huibregtse, Inge L., Biessen‐van Beek, Dorien T. J., Mulder, Sasja F., Saveur, Lisette, Kerst, J. Martijn, Zweers, Danielle, Suelmann, Britt B. M., Wit, Ronald, Reijm, Agnes, Baalen, Sophia, Butterly, Lynn F., Hisey, William M., Robinson, Christina M., Vuuren, Anneke J., Carvalho, Beatriz, Lansdorp‐Vogelaar, Iris, Schaapveld, Michael, Leeuwen, Flora E., Snaebjornsson, Petur, Leerdam, Monique E.

“…Testicular cancer survivors (TCS) treated with platinum‐based chemotherapy have an increased risk of colorectal cancer (CRC). We determined the yield of…”
Get full text

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study by Rutter, Carolyn M, Kim, Jane J, Meester, Reinier G S, Sprague, Brian L, Burger, Emily A, Zauber, Ann G, Ergun, Mehmet Ali, Campos, Nicole G, Doubeni, Chyke A, Trentham-Dietz, Amy, Sy, Stephen, Alagoz, Oguzhan, Stout, Natasha, Lansdorp-Vogelaar, Iris, Corley, Douglas A, Tosteson, Anna N A

“…Patients who receive an abnormal cancer screening result require follow-up for diagnostic testing, but the time to follow-up varies across patients and…”
Get full text

Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening Strategies by HYUNSOON CHO, KLABUNDE, Carrie N, YABROFF, K. Robin, ZHUOQIAO WANG, MEEKINS, Angela, LANSDORP-VOGELAAR, Iris, MARIOTTO, Angela B

“…Many guidelines recommend considering health status and life expectancy when making cancer screening decisions for elderly persons. To estimate life expectancy…”
Get full text

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer by Heijnsdijk, Eveline A.M., Nieboer, Daan, Garg, Tullika, Lansdorp‐Vogelaar, Iris, Koning, Harry J., Nielsen, Matthew E.

“…Objective To estimate the cost‐effectiveness of surveillance schedules for non‐muscle‐invasive bladder cancer (NMIBC) amongst older adults. Patients and…”
Get full text